The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma
Authors
Keywords
-
Journal
Translational Oncology
Volume 37, Issue -, Pages 101775
Publisher
Elsevier BV
Online
2023-09-06
DOI
10.1016/j.tranon.2023.101775
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma
- (2022) Weixiong Yang et al. Journal for ImmunoTherapy of Cancer
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
- (2022) Zi-Xian Wang et al. CANCER CELL
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
- (2021) Robin Park et al. Cancers
- A nomogram‑based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer
- (2021) Lingxiong Wang et al. Molecular and Clinical Oncology
- Prognostic significance of macrophage migration inhibitory factor expression in cancer patients
- (2020) Hyun Min Koh et al. MEDICINE
- Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
- (2020) Xue‐Feng Leng et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
- Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
- (2020) Mariano Provencio et al. LANCET ONCOLOGY
- MIF-Dependent Control of Tumor Immunity
- (2020) Jordan T. Noe et al. Frontiers in Immunology
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β
- (2018) Rui-Min Liu et al. CANCER LETTERS
- Oesophageal cancer
- (2017) Jesper Lagergren et al. LANCET
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Strategies to improve outcomes in esophageal adenocarcinoma
- (2014) Andrew Cowie et al. Expert Review of Anticancer Therapy
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice
- (2012) S. Choi et al. JOURNAL OF IMMUNOLOGY
- Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma
- (2011) Yi-Ming Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link
- (2010) H. Conroy et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started